Evelo Biosciences, Inc. (41) | Development Agreements (1)

Recent Contracts

Development and Clinical Master Services Agreement between Evelo Biosciences, Inc. and Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany dated December 17, 2020 (Filed With SEC on March 9, 2021)